This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morimoto, H. Articles by Bonavida, B. Search for Related Content PubMed PubMed Citation Articles by Morimoto, H. Articles by Bonavida, B.

Overcoming Tumor Necrosis Factor and Drug Resistance of Human Tumor Cell Lines by Combination Treatment with Anti-Fas Antibody and Drugs or Toxins¹

Department of Microbiology and Immunology and the Jonsson Comprehensive Cancer Center, UCLA School of Medicine, University of California at Los Angeles, Los Angeles, California 90024 [H. M., B. B.], and the Biotechnology Institute, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan [S. Y.]

Monoclonal mouse anti-Fas antibody is directed against Fas antigen, a M_r 36,000 encoded polypeptide that belongs to the family of cell surface proteins which includes nerve growth factor receptor, tumor necrosis factor (TNF) receptors, B-cell antigen CD40, and T-cell antigens OX40. Anti-Fas antibody mimics TNF- in its cytolytic activity but not in other TNF--mediated activities. Thus, we examined if anti-Fas antibody synergizes in cytotoxicity with toxins and drugs. The present studies demonstrate that anti-Fas antibody in combination with diphtheria toxin (DTX), Adriamycin, or cis-platinum results in enhanced cytotoxicity and synergy and also overrides resistance to TNF, drugs, or toxins when tested against a battery of human tumor cell lines. Synergy with anti-Fas and DTX requires that DTX is enzymatically active, since inhibitors of DTX-mediated protein synthesis inhibition resulted in loss of synergy. When the plant toxin ricin was used, there was no synergy with anti-Fas antibody but rather an additive effect. The synergy was not obtained in a TNF receptor-negative line but was achieved with other anti-Fas-resistant lines. Cell lines resistant to either Adriamycin or cis-platinum were rendered sensitive by the combination of drug and anti-Fas antibody. Further, combination treatment of anti-Fas and Adriamycin overcame resistance of the gp 170-expressing, multidrug-resistant MDR ovarian line. In all cases, cytotoxicity was augmented by pretreatment of target cells with -interferon which upregulates Fas antigen expression. These results show that anti-Fas antibody can synergize in cytotoxicity with toxins and chemotherapeutic drugs, and combination treatment can reverse resistance to TNF, toxins, and/or drugs.

¹ This work was supported in part by a grant from Institut Henri Beaufour, France.

² To whom requests for reprints should be addressed, at Department of Microbiology and Immunology UCLA School of Medicine, Los Angeles, CA 90024.

Received 11/ 9/92. Accepted 3/25/93.

This article has been cited by other articles:

				K. A Margalit, R. G Cowan, R. M Harman, and S. M Quirk Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling Reproduction, November 1, 2005; 130(5): 751 - 758. [Abstract] [Full Text] [PDF]

				H. J. Garban and B. Bonavida Nitric Oxide Inhibits the Transcription Repressor Yin-Yang 1 Binding Activity at the Silencer Region of the Fas Promoter: A Pivotal Role for Nitric Oxide in the Up-Regulation of Fas Gene Expression in Human Tumor Cells J. Immunol., July 1, 2001; 167(1): 75 - 81. [Abstract] [Full Text] [PDF]

				P. J. Frost, L. H. Butterfield, V. B. Dissette, J. S. Economou, and B. Bonavida Immunosensitization of Melanoma Tumor Cells to Non-MHC Fas-Mediated Killing by MART-1-Specific CTL Cultures J. Immunol., March 1, 2001; 166(5): 3564 - 3573. [Abstract] [Full Text] [PDF]

				T. H. Holmstrom, S. E. F. Tran, V. L. Johnson, N. G. Ahn, S. C. Chow, and J. E. Eriksson Inhibition of Mitogen-Activated Kinase Signaling Sensitizes HeLa Cells to Fas Receptor-Mediated Apoptosis Mol. Cell. Biol., September 1, 1999; 19(9): 5991 - 6002. [Abstract] [Full Text] [PDF]

				S. M. Quirk, D. A. Porter, S. C. Huber, and R. G. Cowan Potentiation of Fas-Mediated Apoptosis of Murine Granulosa Cells by Interferon-{gamma}, Tumor Necrosis Factor-{alpha}, and Cycloheximide Endocrinology, December 1, 1998; 139(12): 4860 - 4869. [Abstract] [Full Text] [PDF]

				S. M. Quirk, R. G. Cowan, and S. H. Huber Fas Antigen-Mediated Apoptosis of Ovarian Surface Epithelial Cells Endocrinology, November 1, 1997; 138(11): 4558 - 4566. [Abstract] [Full Text] [PDF]

				H. J. Garban and B. Bonavida Nitric Oxide Disrupts H2O2-dependent Activation of Nuclear Factor kappa B. ROLE IN SENSITIZATION OF HUMAN TUMOR CELLS TO TUMOR NECROSIS FACTOR-alpha -INDUCED CYTOTOXICITY J. Biol. Chem., March 16, 2001; 276(12): 8918 - 8923. [Abstract] [Full Text] [PDF]